Hormonal optimization of ovarian function in women of advanced reproductive age with diminished ovarian reserve
- 24 February 2025
- journal article
- Published by ECO-Vector LLC in V.F.Snegirev Archives of Obstetrics and Gynecology
- Vol. 12 (1) , 66-74
Abstract
BACKGROUND: In reproductive medicine, diminished ovarian reserve remains a pressing challenge, particularly in the search for effective strategies to address it. Surgical methods for ovarian activation are actively being investigated, along with ongoing research into hormonal therapies. In this context, researchers worldwide have focused on the potential application of dehydroepiandrosterone (DHEA) to improve ovarian reserve in women of advanced reproductive age who are planning pregnancy. AIM: To evaluate the effects of DHEA administration on hormonal profile changes and ovarian reserve parameters in women of advanced reproductive age with diminished ovarian reserve, as well as to assess pregnancy and live birth rates in this population. METHODS: The study included 118 women of advanced reproductive age diagnosed with diminished ovarian reserve. All participants underwent hormonal evaluation on days 2–3 of the menstrual cycle, including measurements of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin, anti-Müllerian hormone (AMH), and inhibin B, as well as folliculometry. The participants were then prescribed DHEA at 75 mg/day, with follow-up hormonal evaluation at 3, 6, and 8 months, along with repeated folliculometry. After treatment completion, data were analyzed, and pregnancy rates were evaluated. RESULTS: DHEA administration at 75 mg/day for 8 months was associated with a significant reduction in gonadotropin levels (FSH: 9.91 [8.60; 10.90], LH: 7.63 [6.40; 8.60]) and an elevation in estradiol levels (90.22 [78.90; 107.60]; p 0.001). A significant improvement in ovarian reserve parameters was observed, as evidenced by changes in laboratory markers (AMH: 1.08 [0.76; 1.40], inhibin B: 98.38 [88.60; 111.40]; p 0.001) and ultrasound folliculometry findings, which demonstrated an increase in antral follicle count to 6–7. A significant reduction in the frequency of menstrual cycle irregularities was observed, with the incidence decreasing to 29.2% (26/118). Pregnancy occurred in 31.3% of women (37/118), with spontaneous conception in 62.1% (23/37) and conception achieved via in vitro fertilization in 37.8% (14/37). A live birth rate of 70.2% (26/37) was recorded, whereas 29.7% (11/37) of pregnancies ended in spontaneous miscarriage. CONCLUSION: DHEA administration at 75 mg/day for 8 months in women of advanced reproductive age with diminished ovarian reserve is associated with improvements in ovarian reserve parameters and an increased likelihood of achieving a desired pregnancy.Keywords
This publication has 14 references indexed in Scilit:
- The Effect of Dehydroepiandrosterone (DHEA) Supplementation on IVF or ICSI: A Meta-Analysis of Randomized Controlled TrialsGeburtshilfe und Frauenheilkunde, 2019
- Long‐term outcome of ovarian function in women with intermittent premature ovarian insufficiencyClinical Endocrinology, 2016
- Genetics of primary ovarian insufficiency: new developments and opportunitiesHuman Reproduction Update, 2015
- Ovarian antral folliculogenesis during the human menstrual cycle: a reviewHuman Reproduction Update, 2011
- In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNAMolecular Human Reproduction, 2010
- DNA damage and repair in human oocytes and embryos: a reviewZygote, 2010
- Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS)Reproductive Biology and Endocrinology, 2010
- Premature ovarian failure and dehydroepiandrosteroneFertility and Sterility, 2009
- Role of 17β-Hydroxysteroid Dehydrogenases in Sex Steroid Formation in Peripheral Intracrine TissuesTrends in Endocrinology & Metabolism, 2000
- Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case seriesHuman Reproduction, 2000